<table id="table15" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 15: Drug Interactions: Pharmacokinetic Parameters for Co-administered Drugs in the Presence of Darunavir/Ritonavir</caption>
<col align="left" span="1" valign="top" width="15%"></col>
<col align="center" span="1" valign="top" width="25%"></col>
<col align="center" span="1" valign="top" width="20%"></col>
<col align="center" span="1" valign="top" width="5%"></col>
<col align="center" span="1" valign="top" width="5%"></col>
<col align="center" span="1" valign="top" width="10%"></col>
<col align="center" span="1" valign="top" width="10%"></col>
<col align="center" span="1" valign="top" width="10%"></col>
<tbody>
<tr>
<th colspan="1">Co-Administered Drug</th>
<th colspan="2">Dose/Schedule</th>
<th colspan="1">N</th>
<th colspan="1">PK</th>
<th colspan="3">LS Mean Ratio (90% CI) of <content stylecode="underline">Co-Administered Drug</content> Pharmacokinetic Parameters With/Without Darunavir<br/>No effect =1.00</th>
</tr>
<tr>
<th colspan="1">Co-Administered Drug</th>
<th colspan="1">Darunavir/<br/>ritonavir</th>
<th colspan="1">C<sub>max</sub>
</th>
<th colspan="1">AUC</th>
<th colspan="1">C<sub>min</sub>
</th>
</tr>
<tr>
<td>
<content stylecode="bold">Co-Administration With Other HIV Protease Inhibitors</content>
</td>
</tr>
<tr>
<td>Atazanavir</td>
<td>300 mg q.d.<linkhtml href="#footnote-8">*</linkhtml> /100 mg ritonavir q.d. when administered alone</td>
<td>400/100 mg b.i.d. <linkhtml href="#footnote-9">†</linkhtml>
</td>
<td>13</td>
<td>↔</td>
<td>0.89<br/>(0.78–1.01)</td>
<td>1.08<br/>(0.94–1.24)</td>
<td>1.52<br/>(0.99–2.34)</td>
</tr>
<tr>
<td></td>
<td>300 mg q.d. when administered with darunavir/ritonavir</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Indinavir</td>
<td>800 mg b.i.d. /100 mg ritonavir b.i.d. when administered alone</td>
<td>400/100 mg b.i.d.</td>
<td>9</td>
<td>↑</td>
<td>1.08<br/>(0.95–1.22)</td>
<td>1.23<br/>(1.06–1.42)</td>
<td>2.25<br/>(1.63–3.10)</td>
</tr>
<tr>
<td></td>
<td>800 mg b.i.d. when administered with darunavir/<br/> ritonavir<br/>
</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Lopinavir/Ritonavir</td>
<td>400/100 mg b.i.d.<linkhtml href="#footnote-10">‡</linkhtml>
</td>
<td>1200/100 mg b.i.d.</td>
<td>14</td>
<td>↔</td>
<td>0.98<br/>(0.78–1.22)</td>
<td>1.09<br/>(0.86–1.37)</td>
<td>1.23<br/>(0.90–1.69)</td>
</tr>
<tr>
<td></td>
<td>533/133.3 mg b.i.d.<footnoteref idref="t15ft3"></footnoteref>
</td>
<td>1200 mg b.i.d.</td>
<td>15</td>
<td>↔</td>
<td>1.11<br/>(0.96–1.30)</td>
<td>1.09<br/>(0.96–1.24)</td>
<td>1.13<br/>(0.90–1.42)</td>
</tr>
<tr>
<td>Saquinavir hard gel capsule</td>
<td>1000 mg b.i.d. /100 mg ritonavir b.i.d. when administered alone</td>
<td>400/100 mg b.i.d.</td>
<td>12</td>
<td>↔</td>
<td>0.94<br/>(0.78–1.13)</td>
<td>0.94<br/>(0.76–1.17)</td>
<td>0.82<br/>(0.52–1.30)</td>
</tr>
<tr>
<td></td>
<td>1000 mg b.i.d. when administered with darunavir/ritonavir</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>
<content stylecode="bold">Co-Administration With Other HIV Antiretrovirals</content>
</td>
</tr>
<tr>
<td>Didanosine</td>
<td>400 mg q.d.</td>
<td>600/100 mg b.i.d.</td>
<td>17</td>
<td>↔</td>
<td>0.84<br/>(0.59–1.20)</td>
<td>0.91<br/>(0.75–1.10)</td>
<td>-</td>
</tr>
<tr>
<td>Efavirenz</td>
<td>600 mg q.d.</td>
<td>300/100 mg b.i.d.</td>
<td>12</td>
<td>↑</td>
<td>1.15<br/>(0.97–1.35)</td>
<td>1.21<br/>(1.08–1.36)</td>
<td>1.17<br/>(1.01–1.36)</td>
</tr>
<tr>
<td>Etravirine</td>
<td>100 mg b.i.d.</td>
<td>600/100 mg b.i.d.</td>
<td>14</td>
<td>↓</td>
<td>0.68<br/>(0.57–0.82)</td>
<td>0.63<br/>(0.54–0.73)</td>
<td>0.51<br/>(0.44–0.61)</td>
</tr>
<tr>
<td>Nevirapine</td>
<td>200 mg b.i.d.</td>
<td>400/100 mg b.i.d.</td>
<td>8</td>
<td>↑</td>
<td>1.18<br/>(1.02–1.37)</td>
<td>1.27<br/>(1.12–1.44)</td>
<td>1.47<br/>(1.20–1.82)</td>
</tr>
<tr>
<td>Rilpivirine</td>
<td>150 mg q.d.</td>
<td>800/100 mg q.d.</td>
<td>14</td>
<td>↑</td>
<td>1.79 <br/>(1.56–2.06)</td>
<td>2.30 <br/>(1.98–2.67)</td>
<td>2.78 <br/>(2.39–3.24)</td>
</tr>
<tr>
<td>Tenofovir Disoproxil Fumarate</td>
<td>300 mg q.d.</td>
<td>300/100 mg b.i.d.</td>
<td>12</td>
<td>↑</td>
<td>1.24<br/>(1.08–1.42)</td>
<td>1.22<br/>(1.10–1.35)</td>
<td>1.37<br/>(1.19–1.57)</td>
</tr>
<tr>
<td>Maraviroc</td>
<td>150 mg b.i.d.</td>
<td>600/100 mg b.i.d.</td>
<td>12</td>
<td>↑</td>
<td>2.29<br/>(1.46–3.59)</td>
<td>4.05<br/>(2.94–5.59)</td>
<td>8.00<br/>(6.35–10.1)</td>
</tr>
<tr>
<td>Maraviroc</td>
<td>150 mg b.i.d.</td>
<td>600/100 mg b.i.d. with 200 mg b.i.d. etravirine</td>
<td>10</td>
<td>↑</td>
<td>1.77<br/>(1.20–2.60)</td>
<td>3.10<br/>(2.57–3.74)</td>
<td>5.27<br/>(4.51–6.15)</td>
</tr>
<tr>
<td>
<content stylecode="bold">Co-Administration With HCV NS3-4A Protease Inhibitors</content>
</td>
</tr>
<tr>
<td>Boceprevir</td>
<td>800 mg three times daily</td>
<td>600/100 mg b.i.d.</td>
<td>12<linkhtml href="#footnote-11">§</linkhtml>
</td>
<td>↓</td>
<td>0.75<br/>(0.67–0.85)</td>
<td>0.68<br/>(0.65–0.72)</td>
<td>0.65<br/>(0.56–0.76)</td>
</tr>
<tr>
<td>Telaprevir</td>
<td>750 mg every 8 hours</td>
<td>600/100 mg b.i.d.</td>
<td>11<linkhtml href="#footnote-12">¶</linkhtml>
</td>
<td>↓</td>
<td>0.64 <br/>(0.61–0.67)</td>
<td>0.65 <br/>(0.61–0.69)</td>
<td>0.68 <br/>(0.63–0.74)</td>
</tr>
<tr>
<td>
<content stylecode="bold">Co-Administration With Other Drugs</content>
</td>
</tr>
<tr>
<td>Atorvastatin</td>
<td>40 mg q.d. when administered alone</td>
<td>300/100 mg b.i.d.</td>
<td>15</td>
<td>↑</td>
<td>0.56<br/>(0.48–0.67)</td>
<td>0.85<br/>(0.76–0.97)</td>
<td>1.81<br/>(1.37–2.40)</td>
</tr>
<tr>
<td></td>
<td>10 mg q.d. when administered with darunavir/ritonavir</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Artemether</td>
<td>80 mg single dose</td>
<td>600/100 mg b.i.d.</td>
<td>15</td>
<td>↓</td>
<td>0.85<br/>(0.68–1.05)</td>
<td>0.91<br/>(0.78–1.06)</td>
<td>-</td>
</tr>
<tr>
<td>Dihydroartemisinin</td>
<td></td>
<td></td>
<td>15</td>
<td>↑</td>
<td>1.06<br/>(0.82–1.39)</td>
<td>1.12<br/>(0.96–1.30)</td>
<td>-</td>
</tr>
<tr>
<td>Artemether</td>
<td>Artemether/lumefantrine  80/480 mg (6 doses at 0, 8, 24, 36, 48, and 60 hours)</td>
<td>600/100 mg b.i.d.</td>
<td>15</td>
<td>↓</td>
<td>0.82<br/>(0.61–1.11)</td>
<td>0.84<br/>(0.69–1.02)</td>
<td>0.97<br/>(0.90–1.05)</td>
</tr>
<tr>
<td>Dihydroartemisinin</td>
<td></td>
<td>15</td>
<td>↓</td>
<td>0.82<br/>(0.66–1.01)</td>
<td>0.82<br/>(0.74–0.91)</td>
<td>1.00<br/>(0.82–1.22)</td>
</tr>
<tr>
<td>Lumefantrine</td>
<td></td>
<td>15</td>
<td>↑</td>
<td>1.65<br/>(1.49–1.83)</td>
<td>2.75<br/>(2.46–3.08)</td>
<td>2.26<br/>(1.92–2.67)</td>
</tr>
<tr>
<td>Buprenorphine/ Naloxone</td>
<td>8/2 mg to 16/4 mg q.d.</td>
<td>600/100 mg b.i.d.</td>
<td>17</td>
<td>↔</td>
<td>0.92 <linkhtml href="#footnote-13">#</linkhtml>
<br/>(0.79–1.08)</td>
<td>0.89 <footnoteref idref="t15-ft"></footnoteref>
<br/>(0.78–1.02)</td>
<td>0.98 <footnoteref idref="t15-ft"></footnoteref>
<br/>(0.82–1.16)</td>
</tr>
<tr>
<td>Norbuprenorphine</td>
<td></td>
<td></td>
<td>17</td>
<td>↑</td>
<td>1.36<br/>(1.06–1.74)</td>
<td>1.46<br/>(1.15–1.85)</td>
<td>1.71<br/>(1.29–2.27)</td>
</tr>
<tr>
<td>Carbamazepine</td>
<td>200 mg b.i.d.</td>
<td>600/100 mg b.i.d.</td>
<td>16</td>
<td>↑</td>
<td>1.43<br/>(1.34–1.53)</td>
<td>1.45<br/>(1.35–1.57)</td>
<td>1.54<br/>(1.41–1.68)</td>
</tr>
<tr>
<td>Carbamazepine epoxide</td>
<td></td>
<td></td>
<td>16</td>
<td>↓</td>
<td>0.46<br/>(0.43–0.49)</td>
<td>0.46<br/>(0.44–0.49)</td>
<td>0.48<br/>(0.45–0.51)</td>
</tr>
<tr>
<td>Clarithromycin</td>
<td>500 mg b.i.d.</td>
<td>400/100 mg b.i.d.</td>
<td>17</td>
<td>↑</td>
<td>1.26<br/>(1.03–1.54)</td>
<td>1.57<br/>(1.35–1.84)</td>
<td>2.74<br/>(2.30–3.26)</td>
</tr>
<tr>
<td>Dextromethorphan</td>
<td>30 mg</td>
<td>600/100 mg b.i.d.</td>
<td>12</td>
<td>↑</td>
<td>2.27<br/>(1.59–3.26)</td>
<td>2.70<br/>(1.80–4.05)</td>
<td>-</td>
</tr>
<tr>
<td>Dextrorphan</td>
<td></td>
<td></td>
<td></td>
<td>↓</td>
<td>0.87<br/>(0.77–0.98)</td>
<td>0.96<br/>(0.90–1.03)</td>
<td>-</td>
</tr>
<tr>
<td>Digoxin</td>
<td>0.4 mg</td>
<td>600/100 mg b.i.d.</td>
<td>8</td>
<td>↑</td>
<td>1.15<br/> (0.89–1.48)</td>
<td>1.36<br/> (0.81–2.27)</td>
<td>-</td>
</tr>
<tr>
<td>Ethinyl estradiol (EE)</td>
<td>Ortho-Novum 1/35<br/>(35 µg EE / 1 mg NE)</td>
<td>600/100 mg b.i.d.</td>
<td>11</td>
<td>↓</td>
<td>0.68<br/>(0.61–0.74)</td>
<td>0.56<br/>(0.50–0.63)</td>
<td>0.38<br/>(0.27–0.54)</td>
</tr>
<tr>
<td>Norethindrone (NE)</td>
<td></td>
<td></td>
<td>11</td>
<td>↓</td>
<td>0.90<br/>(0.83–0.97)</td>
<td>0.86<br/>(0.75–0.98)</td>
<td>0.70<br/>(0.51–0.97)</td>
</tr>
<tr>
<td>Ketoconazole</td>
<td>200 mg b.i.d.</td>
<td>400/100 mg b.i.d.</td>
<td>15</td>
<td>↑</td>
<td>2.11<br/>(1.81–2.44)</td>
<td>3.12<br/>(2.65–3.68)</td>
<td>9.68<br/>(6.44–14.55)</td>
</tr>
<tr>
<td>R-Methadone</td>
<td>55–150 mg q.d.</td>
<td>600/100 mg b.i.d.</td>
<td>16</td>
<td>↓</td>
<td>0.76<br/>(0.71–0.81)</td>
<td>0.84<br/>(0.78–0.91)</td>
<td>0.85<br/>(0.77–0.94)</td>
</tr>
<tr>
<td>Omeprazole</td>
<td>40 mg single dose</td>
<td>600/100 mg b.i.d.</td>
<td>12</td>
<td>↓</td>
<td>0.66<br/>(0.48–0.90)</td>
<td>0.58<br/>(0.50–0.66)</td>
<td>-</td>
</tr>
<tr>
<td>5-hydroxy omeprazole</td>
<td></td>
<td></td>
<td></td>
<td>↓</td>
<td>0.93<br/>(0.71–1.21)</td>
<td>0.84<br/>(0.77–0.92)</td>
<td>-</td>
</tr>
<tr>
<td>Paroxetine</td>
<td>20 mg q.d.</td>
<td>400/100 mg b.i.d.</td>
<td>16</td>
<td>↓</td>
<td>0.64<br/>(0.59–0.71)</td>
<td>0.61<br/>(0.56–0.66)</td>
<td>0.63<br/>(0.55–0.73)</td>
</tr>
<tr>
<td>Pravastatin</td>
<td>40 mg single dose</td>
<td>600/100 mg b.i.d.</td>
<td>14</td>
<td>↑</td>
<td>1.63<br/>(0.95–2.82)</td>
<td>1.81<br/>(1.23–2.66)</td>
<td>-</td>
</tr>
<tr>
<td>Rifabutin</td>
<td>150 mg q.o.d. <linkhtml href="#footnote-14">Þ</linkhtml> when administered with PREZISTA/ritonavir</td>
<td>600/100 mg b.i.d. <linkhtml href="#footnote-15">ß</linkhtml>
</td>
<td>11</td>
<td>↑</td>
<td>0.72<br/>(0.55–0.93)</td>
<td>0.93<br/>(0.80–1.09)</td>
<td>1.64<br/>(1.48–1.81)</td>
</tr>
<tr>
<td>25-<content stylecode="italics">O</content>-desacetyl-rifabutin</td>
<td>300 mg q.d. when administered alone</td>
<td></td>
<td>11</td>
<td>↑</td>
<td>4.77<br/>(4.04–5.63)</td>
<td>9.81<br/>(8.09–11.9)</td>
<td>27.1<br/>(22.2–33.2)</td>
</tr>
<tr>
<td>Sertraline</td>
<td>50 mg q.d.</td>
<td>400/100 mg b.i.d.</td>
<td>13</td>
<td>↓</td>
<td>0.56<br/> (0.49–0.63)</td>
<td>0.51<br/> (0.46–0.58)</td>
<td>0.51<br/> (0.45–0.57)</td>
</tr>
<tr>
<td>Sildenafil</td>
<td>100 mg (single dose) administered alone</td>
<td>400/100 mg b.i.d.</td>
<td>16</td>
<td>↑</td>
<td>0.62<br/>(0.55–0.70)</td>
<td>0.97<br/>(0.86–1.09)</td>
<td>-</td>
</tr>
<tr>
<td></td>
<td>25 mg (single dose) when administered with darunavir/ritonavir</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>S-warfarin</td>
<td>10 mg single dose</td>
<td>600/100 mg b.i.d.</td>
<td>12</td>
<td>↓</td>
<td>0.92<br/>(0.86–0.97)</td>
<td>0.79<br/>(0.73–0.85)</td>
<td>-</td>
</tr>
<tr>
<td>7-OH-S-warfarin</td>
<td></td>
<td></td>
<td>12</td>
<td>↑</td>
<td>1.42<br/>(1.24–1.63)</td>
<td>1.23<br/>(0.97–1.57)</td>
<td>-</td>
</tr>
</tbody>
</table>